TCM
TCG Crossover Management Portfolio holdings
AUM
$876M
This Quarter Return
+44.04%
1 Year Return
+23.66%
3 Year Return
+996.72%
5 Year Return
–
10 Year Return
–
AUM
$333M
AUM Growth
+$333M
(+42%)
Cap. Flow
+$22.1M
Cap. Flow
% of AUM
6.62%
Top 10 Holdings %
Top 10 Hldgs %
83.38%
Holding
25
New
3
Increased
4
Reduced
5
Closed
4
Top Buys
| 1 |
SLN
Silence Therapeutics
SLN
|
$21.1M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$17.3M |
| 3 |
ALLK
Allakos
ALLK
|
$10.1M |
| 4 |
Kura Oncology
KURA
|
$2.47M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$1.95M |
Top Sells
| 1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$13.9M |
| 2 |
Geron
GERN
|
$6.97M |
| 3 |
89bio
ETNB
|
$3.65M |
| 4 |
Viridian Therapeutics
VRDN
|
$3.08M |
| 5 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$2.33M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $69.6M | 20.87% | 3,877,903 +963,653 | +33% | +$17.3M |
|
2
Cogent Biosciences
COGT
$1.69B
| $51.9M | 15.58% | 3,481,042 | – | – |
|
|
3
Geron
GERN
$893M
| $28.4M | 8.5% | 12,115,926 -2,980,416 | -20% | -$6.97M |
|
|
4
Viridian Therapeutics
VRDN
$1.5B
| $23.9M | 7.16% | 1,164,000 -150,000 | -11% | -$3.08M |
|
|
SLN
5
Silence Therapeutics
SLN
$227M
| $21.1M | 6.34% | +2,104,875 | New | +$21.1M |
|
|
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
| $20.7M | 6.2% | 5,905,400 | – | – |
|
|
7
Kura Oncology
KURA
$686M
| $18.4M | 5.53% | 1,348,642 +181,000 | +16% | +$2.47M |
|
8
Aclaris Therapeutics
ACRS
$209M
| $18M | 5.41% | 1,144,939 | – | – |
|
|
JBIO
9
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $15.9M | 4.77% | 959,572 +70,000 | +8% | +$1.16M |
|
10
Entrada Therapeutics
TRDA
$208M
| $10.1M | 3.04% | 642,189 -21,505 | -3% | -$339K |
|
|
ALLK
11
DELISTED
Allakos
ALLK
| $10.1M | 3.02% | +1,643,500 | New | +$10.1M |
|
|
AKUS
12
DELISTED
Akouos, Inc. Common Stock
AKUS
| $9.13M | 2.74% | 1,350,006 | – | – |
|
13
Tyra Biosciences
TYRA
$675M
| $8.31M | 2.49% | 945,707 +49,289 | +5% | +$433K |
|
14
MoonLake Immunotherapeutics
MLTX
$3.54B
| $7.76M | 2.33% | 1,000,000 | – | – |
|
15
Merus
MRUS
$4.98B
| $6.01M | 1.8% | 300,000 | – | – |
|
16
Tango Therapeutics
TNGX
$747M
| $4.24M | 1.27% | 1,172,250 | – | – |
|
17
Dianthus Therapeutics
DNTH
$759M
| $3M | 0.9% | 2,124,122 | – | – |
|
18
Zai Lab
ZLAB
$3.68B
| $2.49M | 0.75% | 72,777 -22,223 | -23% | -$760K |
|
|
19
Madrigal Pharmaceuticals
MDGL
$9.76B
| $1.95M | 0.58% | +30,000 | New | +$1.95M |
|
|
ALPN
20
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.83M | 0.55% | 254,569 -323,691 | -56% | -$2.33M |
|
|
ELEV
21
DELISTED
Elevation Oncology
ELEV
| $627K | 0.19% | 555,000 | – | – |
|
22
AnaptysBio
ANAB
$569M
| – | – | -58,515 | Closed | -$1.19M |
|
|
23
89bio
ETNB
$1.34B
| – | – | -1,133,196 | Closed | -$3.65M |
|
|
PRDS
24
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| – | – | -59,039 | Closed | -$181K |
|
|
KDNY
25
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – | -796,460 | Closed | -$13.9M |
|